Surprisingly, although NAD+ depletion has been suggested to make SARM1 activation more likely (Figley et al., 2021) we found no clear evidence of any additional depletion of NAD+ under conditions (ZIKV-infection) where SARM1 contributes to axon loss. The gene discussed is SARM1; the disease is infection.